Keros Therapeutics, Inc. Shares of Common Stock ($0.0001 par value per share) SALES AGREEMENTSales Agreement • June 17th, 2024 • Keros Therapeutics, Inc. • Pharmaceutical preparations • New York
Contract Type FiledJune 17th, 2024 Company Industry JurisdictionKeros Therapeutics, Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with SVB Leerink LLC (the “Agent”), as follows: